QPS Holdings, LLC divests its Neuropharmacology Business Unit

NEWARK, Del.–(BUSINESS WIRE)–QPS, a global CRO, sells its Neuropharmacology Unit to Scantox, a Nordic CRO. QPS provides preclinical, bioanalysis, and clinical trial services.
Click here to view original post